<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1343" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1343/" /><meta name="ncbi_pagename" content="Ocular Albinism, X-Linked - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Ocular Albinism, X-Linked - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Ocular Albinism, X-Linked" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/11/19" /><meta name="citation_author" content="Richard Alan Lewis" /><meta name="citation_pmid" content="20301517" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1343/" /><meta name="citation_keywords" content="Nettleship-Falls Ocular Albinism" /><meta name="citation_keywords" content="OA1" /><meta name="citation_keywords" content="Ocular Albinism Type 1" /><meta name="citation_keywords" content="XLOA" /><meta name="citation_keywords" content="Nettleship-Falls Ocular Albinism" /><meta name="citation_keywords" content="OA1" /><meta name="citation_keywords" content="Ocular Albinism Type 1" /><meta name="citation_keywords" content="XLOA" /><meta name="citation_keywords" content="G-protein coupled receptor 143" /><meta name="citation_keywords" content="GPR143" /><meta name="citation_keywords" content="Ocular Albinism, X-Linked" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Ocular Albinism, X-Linked" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Richard Alan Lewis" /><meta name="DC.Date" content="2015/11/19" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1343/" /><meta name="description" content="X-linked ocular albinism (XLOA) is a disorder of melanosome biogenesis leading to minor cutaneous and adnexal manifestations and congenital and persistent visual impairment in affected males. XLOA is characterized by infantile nystagmus, reduced visual acuity, hypopigmentation of the iris pigment epithelium and the ocular fundus, and foveal hypoplasia. Significant refractive errors, reduced or absent binocular functions, photoaversion, and strabismus are common. XLOA is a non-progressive disorder and the visual acuity remains stable throughout life, often slowly improving into the mid-teens." /><meta name="og:title" content="Ocular Albinism, X-Linked" /><meta name="og:type" content="book" /><meta name="og:description" content="X-linked ocular albinism (XLOA) is a disorder of melanosome biogenesis leading to minor cutaneous and adnexal manifestations and congenital and persistent visual impairment in affected males. XLOA is characterized by infantile nystagmus, reduced visual acuity, hypopigmentation of the iris pigment epithelium and the ocular fundus, and foveal hypoplasia. Significant refractive errors, reduced or absent binocular functions, photoaversion, and strabismus are common. XLOA is a non-progressive disorder and the visual acuity remains stable throughout life, often slowly improving into the mid-teens." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1343/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/x-oa/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1343/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89A79AE04134B100000000006C0038.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1343_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1343_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/dfnb9/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/oca1/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1343_"><span class="title" itemprop="name">Ocular Albinism, X-Linked</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Nettleship-Falls Ocular Albinism, OA1, Ocular Albinism Type 1, XLOA</div><p class="contrib-group"><span itemprop="author">Richard Alan Lewis</span>, MD, MS.</p><a data-jig="ncbitoggler" href="#__NBK1343_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1343_ai__"><div class="contrib half_rhythm"><span itemprop="author">Richard Alan Lewis</span>, MD, MS<div class="affiliation small">Departments of Ophthalmology, Medicine, Pediatrics, and Molecular and Human Genetics<br />Huffington Center on Aging<br />Cullen Eye Institute<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@siwelr" class="oemail">ude.mcb@siwelr</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">March 12, 2004</span>; Last Update: <span itemprop="dateModified">November 19, 2015</span>.</p><p><em>Estimated reading time: 24 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="x-oa.Summary" itemprop="description"><h2 id="_x-oa_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> ocular albinism (XLOA) is a disorder of melanosome biogenesis leading to minor cutaneous and adnexal manifestations and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> and persistent visual impairment in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males. XLOA is characterized by infantile nystagmus, reduced visual acuity, hypopigmentation of the iris pigment epithelium and the ocular fundus, and foveal hypoplasia. Significant refractive errors, reduced or absent binocular functions, photoaversion, and strabismus are common. XLOA is a non-progressive disorder and the visual acuity remains stable throughout life, often slowly improving into the mid-teens.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>A diagnosis of ocular albinism (OA) is probable in the presence of infantile nystagmus, iris translucency, substantial hypopigmentation of the ocular fundus periphery in males with mildly hypopigmented skin (most notably when compared to unaffected sibs), foveal hypoplasia, reduced visual acuity, and aberrant optic pathway projection as demonstrated by crossed asymmetry of the cortical responses on visual evoked potential testing. <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance is documented by either a family history consistent with X-linked inheritance or the presence of typical <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> signs (irregular retinal pigmentation and mild iris transillumination) in an <a class="def" href="/books/n/gene/glossary/def-item/obligate-carrier/">obligate carrier</a> female. Molecular genetic testing of <i>GPR143</i>
<i>(</i>previously <i>OA1</i>) detects pathogenic variants in more than 90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Early detection and correction of refractive errors, use of sunglasses or special filter glasses for photoaversion, and prismatic spectacle correction for abnormal head posture. Strabismus surgery is often unnecessary but may be performed to improve peripheral visual fusion fields. The need for vision aids and special consideration in educational settings should be addressed.</p><p><i>Surveillance</i>: For <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children younger than age 16 years: annual ophthalmologic examination (including assessment of refractive error and the need for filter glasses) and psychosocial and educational support. For adults: ophthalmologic examinations as needed.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>XLOA is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. An <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male transmits the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to all of his daughters and none of his sons. The risk to the sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of the mother. If the mother is a carrier, the chance of transmitting the <i>GPR143</i> pathogenic variant in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be affected; female sibs who inherit the pathogenic variant will be carriers and will usually not be affected. Carrier testing of at-risk female relatives is most informative if the pathogenic variant has been identified in the proband. Prenatal testing is possible for pregnancies at increased risk if the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> pathogenic variant is known.</p></div></div><div id="x-oa.Diagnosis"><h2 id="_x-oa_Diagnosis_">Diagnosis</h2><div id="x-oa.Suggestive_Findings"><h3>Suggestive Findings</h3><div id="x-oa.Males"><h4>Males</h4><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> ocular albinism (XLOA) <b>should be suspected</b> in males with the following findings:</p><p><b>Ophthalmologic</b> (common to all forms of albinism)</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Infantile nystagmus.</b> Nystagmus usually develops during the first three months of life and may be preceded by a period of poor fixation and poor visual contact, giving rise to a suspicion of delayed visual maturation or cerebral visual impairment (CVI). The nystagmus is most frequently of the pendular or jerk type and is sometimes associated with head nodding (titubation). With age, the nystagmus tends to diminish, although it rarely disappears completely.</div><div class="half_rhythm">Nystagmus amplitude and/or frequency often varies with horizontal gaze position. The gaze position in which the nystagmus is least severe is known as the null point. At the null point, the decrease in ocular oscillations reduces retinal image motion and thereby maximizes visual acuity. Therefore, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals whose null point is eccentrically located will adopt a compensatory face turn. A similar dampening of nystagmus can be obtained with the convergence that occurs with focus at a close range; thus, visual acuity at close range tends to be better than visual acuity tested at distance.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Hypopigmentation of the iris.</b> Iris transillumination caused by hypopigmentation of the iris pigment epithelium (IPE), the posterior layer of the iris, is a frequent finding that is best visualized in a dark room by trans-scleral illumination with a light source placed directly on the bulbar conjunctiva or by slit lamp examination in which a strong beam is directed through an undilated pupil. Normally, incident light reflected from within the eye exits only through the pupil because it is blocked by the IPE. In albinism, reflected light can penetrate the iris. Since punctate iris transillumination defects can be seen in some individuals with light complexion, detection of these defects alone in this group is not a reliable indicator of albinism.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Hypopigmentation of the ocular fundus</b> resulting from decreased concentration of pigment in the retinal pigment epithelium (RPE), which allows visualization of the choroidal vessels. The hypopigmentation is generally more profound in the periphery of the ocular fundus.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Foveal hypoplasia,</b> characterized by diminution or absence of the foveal pit (umbo) and the annular foveal reflex. The foveal area is inconspicuous and sometimes retinal vessels extend through the normally avascular fovea. Optical coherence tomography (OCT) can document the retinal thinning. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males in pedigrees with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> nystagmus and molecular confirmation of XLOA have foveal hypoplasia as an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> finding [<a class="bk_pop" href="#x-oa.REF.preising.2001.1098">Preising et al 2001</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Reduced visual acuity.</b> In most individuals with albinism, the best corrected visual acuity is between 20/40 (6/12) and 20/200 (6/60). XLOA is a non-progressive disorder and the visual acuity typically slowly improves until mid-to-late teens and then remains stable throughout life.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Aberrant optic pathway projections</b> consisting of an excessive crossing of the retino-striate fibers in the optic chiasm; i.e., the visual input from the right eye is almost exclusively directed towards the left hemisphere and vice-versa [<a class="bk_pop" href="#x-oa.REF.schmitz.2003.16">Schmitz et al 2003</a>, <a class="bk_pop" href="#x-oa.REF.lauronen.2005.820">Lauronen et al 2005</a>]. This "misrouting" can be demonstrated in specialized laboratories by selective VEP technique adapted for use in clinical practice [<a class="bk_pop" href="#x-oa.REF.soong.2000.302">Soong et al 2000</a>, <a class="bk_pop" href="#x-oa.REF.hoffmann.2005.3892">Hoffmann et al 2005</a>]. Lateral placement of recording electrodes over the occipital area allows for the detection of interhemispheric asymmetries in amplitude following monocular stimulation with a pattern-onset grating. Rather than the typical near-equal response from each hemisphere, the response amplitude is disproportionately larger in the hemisphere contralateral to the stimulated eye. Some authors contend that this VEP technique, albeit cumbersome, is a highly sensitive indicator of albinism [<a class="bk_pop" href="#x-oa.REF.sj_str_m.2001.35">Sj&#x000f6;str&#x000f6;m et al 2001</a>]. In several forms of albinism, MR imaging found variations in the size and configuration of the optic chiasm compared to normal controls. However, this feature is neither distinctive nor unique and, thus, is not helpful in clinical diagnosis [<a class="bk_pop" href="#x-oa.REF.schmitz.2003.16">Schmitz et al 2003</a>].</div></li></ul><p><b>Dermatologic</b></p><ul><li class="half_rhythm"><div><b>Hypopigmentation</b> of hair and skin compared to others of the same racial or ethnic backgrounds, especially when compared to unaffected male sibs. Of course, the cutaneous color spectrum is broad and overlaps the entire spectrum of other forms of albinism.</div></li></ul><p>Note: None of the above findings is either specific or obligate for <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> ocular albinism, and the diagnosis may be difficult in blond northern European males with only minimally reduced central visual acuity.</p><p><b>Family history</b></p><ul><li class="half_rhythm"><div>Maternal male relatives with ocular albinism</div></li><li class="half_rhythm"><div>The most consistent clinical diagnostic clue for XLOA: presence of characteristic retinal pigment abnormalities in female relatives who are obligate carriers</div></li></ul></div><div id="x-oa.Heterozygous_Females"><h4>Heterozygous Females</h4><p>Depending on overall ethnic and racial skin and adnexal pigmentation, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females may show iris transillumination and a coarse pattern of blotchy hypo-and hyperpigmentation of the retinal pigment epithelium that becomes more dramatic outside the vascular arcades. Some carriers have isolated patches of hypopigmented skin that does not tan to the same degree as uninvolved skin.</p><p>Rarely, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, showing infantile nystagmus, foveal hypoplasia, reduced visual acuity, and diffuse hypopigmentation of the ocular structures.</p></div></div><div id="x-oa.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of XLOA <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GPR143</i> (see <a class="figpopup" href="/books/NBK1343/table/x-oa.T.summary_of_molecular_genetic_test/?report=objectonly" target="object" rid-figpopup="figxoaTsummaryofmoleculargenetictest" rid-ob="figobxoaTsummaryofmoleculargenetictest">Table 1</a>). If molecular testing is not available, the finding of macromelanosomes on skin biopsy would also establish the diagnosis.</p><p><b>Molecular testing</b> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>GPR143</i> is performed first followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>GPR143</i> and other genes of interest (see <a href="#x-oa.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="x-oa.T.summary_of_molecular_genetic_test" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Summary of Molecular Genetic Testing Used in X-Linked Ocular Albinism</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1343/table/x-oa.T.summary_of_molecular_genetic_test/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__x-oa.T.summary_of_molecular_genetic_test_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_x-oa.T.summary_of_molecular_genetic_test_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_x-oa.T.summary_of_molecular_genetic_test_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_x-oa.T.summary_of_molecular_genetic_test_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_x-oa.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>GPR143</i></td><td headers="hd_h_x-oa.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_x-oa.T.summary_of_molecular_genetic_test_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">43%&#x000a0;<sup>5</sup> (~90%&#x000a0;<sup>6</sup>)</td></tr><tr><td headers="hd_h_x-oa.T.summary_of_molecular_genetic_test_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>7</sup></td><td headers="hd_h_x-oa.T.summary_of_molecular_genetic_test_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">48%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="x-oa.TF.1.1"><p class="no_margin">See <a href="/books/NBK1343/#x-oa.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="x-oa.TF.1.2"><p class="no_margin">See <a href="#x-oa.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="x-oa.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="x-oa.TF.1.4"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>5. </dt><dd><div id="x-oa.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#x-oa.REF.schnur.1998.800">Schnur et al [1998]</a>, <a class="bk_pop" href="#x-oa.REF.hegde.2002.7">Hegde et al [2002]</a>, <a class="bk_pop" href="#x-oa.REF.faug_re.2003.1">Faug&#x000e8;re et al [2003]</a></p></div></dd><dt>6. </dt><dd><div id="x-oa.TF.1.6"><p class="no_margin">Due to the high prevalence of deletions in this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, attempts at <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> may detect amplification failure resulting in an apparent detection rate of ~90% in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males [Personal communications, Baylor Miraca Genetics Laboratory, Houston, TX]. Standard clinical laboratory practice does not consider assay failure to be diagnostic; therefore, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> would be necessary to confirm a diagnosis.</p></div></dd><dt>7. </dt><dd><div id="x-oa.TF.1.7"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used can include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div><div id="x-oa.Clinical_Characteristics"><h2 id="_x-oa_Clinical_Characteristics_">Clinical Characteristics</h2><div id="x-oa.Clinical_Description"><h3>Clinical Description</h3><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> ocular albinism (XLOA) is a disorder of melanosome biogenesis leading to <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> and persistent visual impairment and mild to moderate skin changes in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males.</p><div id="x-oa.Affected_Males"><h4>Affected Males</h4><p><b>Ophthalmologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></b> is shared by all types of albinism, which in typical cases includes infantile nystagmus, reduced visual acuity, hypopigmentation of the iris pigment epithelium and the retinal pigment epithelium, foveal hypoplasia, and abnormal optic pathway projections. None of these findings is, however, either specific or obligate.</p><ul><li class="half_rhythm"><div>Hypersensitivity to light, often called "photoaversion," "photophobia," or more appropriately "photodysphoria," is present in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals but varies in intensity and significance from one individual to another. In some affected individuals, photodysphoria is the most incapacitating symptom.</div></li><li class="half_rhythm"><div>Substantial refractive errors are common, most often as hypermetropia with oblique astigmatism. High myopia or compound myopic astigmatism may occur in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div>Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have reduced or absent binocular functions as a consequence of misrouted optic pathway projections, and ocular misalignment (strabismus). A positive angle lambda is often found in individuals with albinism [<a class="bk_pop" href="#x-oa.REF.brodsky.2004.625">Brodsky &#x00026; Fray 2004</a>].</div></li><li class="half_rhythm"><div>Posterior embryotoxon, a developmental anomaly of the anterior chamber angle, has been reported in 30% of a small series of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males [<a class="bk_pop" href="#x-oa.REF.charles.1993.222">Charles et al 1993</a>].</div></li></ul><p><b>Dermatologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</b> XLOA is characterized by mild cutaneous and adnexal involvement (<i>albinismus solum bulbi</i>), and the universal defect in melanosome biogenesis that may escape clinical notice, if not compared to unaffected sibs. Nevertheless, in families with dark complexion, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males tend to be more lightly pigmented than their unaffected sibs. In some affected males, irregular hypopigmented spots are present on the arms and legs.</p><p><b>Prognosis.</b> Persons with XLOA have normal life span, development, intelligence, and fertility.</p></div><div id="x-oa.Heterozygous_Females_1"><h4>Heterozygous Females</h4><p>Heterozygous females may be considered mosaic with respect to the <i>GPR143</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> because random <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> leads to variable degrees of ocular and cutaneous hypopigmentation.</p><ul><li class="half_rhythm"><div>Most <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females demonstrate iris transillumination, which is most prominent in the periphery of the iris. In addition, the ocular fundus shows an easily recognizable pattern of irregular coarse hypopigmentation of the retinal pigment epithelium in splotches and streaks, more dramatic in the peripheral retina. Carrier signs are present in at least 80% to 90% of heterozygotes. Therefore, absence of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> signs does not exclude a diagnosis of XLOA.</div></li><li class="half_rhythm"><div>On occasion, <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> as severely as males as a result of either skewed <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>, homozygosity for a <i>GPR143</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, or partial or total <a class="def" href="/books/n/gene/glossary/def-item/monosomy/">monosomy</a> of the X chromosome.</div></li></ul></div></div><div id="x-oa.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been identified [<a class="bk_pop" href="#x-oa.REF.schiaffino.1999.108">Schiaffino et al 1999</a>].</p><p>Even in the same family, the cutaneous and adnexal coloration and the visual acuities may vary widely [<a class="bk_pop" href="#x-oa.REF.preising.2011.939">Preising et al 2011</a>, <a class="bk_pop" href="#x-oa.REF.trebu_ak_podkraj_ek.2012.167">Trebu&#x00161;ak Podkraj&#x00161;ek et al 2012</a>].</p></div><div id="x-oa.Prevalence"><h3>Prevalence</h3><p>A minimum birth prevalence of one male in 60,000 live born children has been reported in a Danish cohort [<a class="bk_pop" href="#x-oa.REF.rosenberg.1998.570">Rosenberg &#x00026; Schwartz 1998</a>] and of approximately one in 50,000 in a US cohort [<a class="bk_pop" href="#x-oa.REF.king.1995">King et al 1995</a>].</p></div></div><div id="x-oa.Genetically_Related_Allelic_Disorde"><h2 id="_x-oa_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>With the exception of contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> syndromes, no phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>GPR143.</i></p><p><b>Contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> syndromes.</b> In interstitial deletions of the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> involving genes around Xp23, contiguous gene syndromes may arise. In such cases, XLOA may be associated with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> ichthyosis [<a class="bk_pop" href="#x-oa.REF.schnur.1989.706">Schnur et al 1989</a>], <a href="/books/n/gene/kms/">Kallmann syndrome</a> [<a class="bk_pop" href="#x-oa.REF.zhang.1993.923">Zhang et al 1993</a>], sensorineural deafness [<a class="bk_pop" href="#x-oa.REF.bassi.1999.1604">Bassi et al 1999</a>], and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> nasal pyriform aperture stenosis [<a class="bk_pop" href="#x-oa.REF.somsen.2014.1268">Somsen et al 2014</a>].</p></div><div id="x-oa.Differential_Diagnosis"><h2 id="_x-oa_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>"Congenital" nystagmus</b> is usually the initial clinical sign leading to suspicion of an underlying visual sensory or central nervous system disorder and to an ophthalmologic examination. Congenital or infantile nystagmus (which typically begins two to eight weeks after birth) is not specific or unique to XLOA, as it can appear as an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> finding (so-called primary motor nystagmus) or as part of a hereditary ocular disorder, some of which are <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>. Although infantile nystagmus is often a secondary manifestation of bilateral <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> eye disorders associated with vision loss (e.g., corneal opacities, aniridia, cataracts, retinopathy of prematurity, and optic nerve hypoplasia), the differential diagnosis in males with XLOA is usually limited to visual disorders in which infantile nystagmus is the predominant finding and the eye is anatomically normal.</p><p>A family history of <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance for similarly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals along with typical clinical findings supports the diagnosis of XLOA and further testing may not be indicated. However, when the family history is negative, XLOA must be distinguished from other forms of albinism and from X-linked disorders associated with infantile nystagmus.</p><p><b><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> nystagmus</b> (OMIM <a href="https://omim.org/entry/310700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">310700</a>) is a diagnosis of exclusion, characterized by normal electroretinogram (ERG) and normal optic pathways. In the absence of any demonstrable sensory defect, the involuntary eye movements are denoted "motor nystagmus." More than 50% of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females manifest congenital nystagmus, simulating <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance [<a class="bk_pop" href="#x-oa.REF.kerrison.1999.600">Kerrison et al 1999</a>]. Families with X-linked congenital nystagmus have absence of male-to-male transmission. Three X-<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> loci, Xp11.4, Xp22.2 (<i>GPR143</i>), and Xq26.2 (<i>FRMD7</i>), have been identified. <i>FRMD7</i> may manifest slightly different clinical and oculomotor characteristics than XLOA [<a class="bk_pop" href="#x-oa.REF.kumar.2011.2306">Kumar et al 2011</a>]. See also <a href="/books/n/gene/xl-nystag/"><i>FRMD7</i>-Related Infantile Nystagmus</a>.</p><p>The <b>oculocutaneous albinisms,</b> inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner, include types with moderate pigmentation of skin and hair that may be occasionally misinterpreted as "ocular albinism."</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/oca1/">Oculocutaneous albinism type 1</a> (OCA1) is caused by pathogenic variants in <i>TYR</i> that encodes the protein tyrosinase. Individuals with OCA1A have white hair, white skin that does not tan, and fully translucent irides that do not darken with age. At birth, individuals with OCA1B have white or very light yellow hair that darkens with age, white skin that over time develops some generalized pigment and may tan with sun exposure, and blue irides that change to green/hazel or brown/tan with age. Ocular findings are very similar to those of XLOA. The diagnosis of OCA1 is established by clinical findings of hypopigmentation of the skin and hair and characteristic eye findings.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/oca2/">Oculocutaneous albinism type 2</a> (OCA2) is caused by pathogenic variants in <i>OCA2</i> (previously called <i>P</i>). The amount of cutaneous pigmentation in OCA2 ranges from minimal to near normal. Newborns with OCA2 almost always have pigmented hair, with color ranging from light yellow to blond to brown. Hair color may darken with time. Brown OCA, initially identified in Africans and African Americans with light brown hair and skin, is part of the spectrum of OCA2.</div></li><li class="half_rhythm"><div>Oculocutaneous albinism type 3 (OCA3) (OMIM <a href="http://omim.org/entry/203290" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">203290</a>) is caused by pathogenic variants in <i>TYRP1</i> (encoding tyrosinase-related protein 1, also called glycoprotein 75 or GP 75). Originally described in southern African blacks, the disorder is characterized by bright copper-red hair, lighter tan skin, and diluted pigment in the iris and fundus. This has been called "rufous oculocutaneous albinism."</div></li><li class="half_rhythm"><div><a href="/books/n/gene/oca4/">Oculocutaneous albinism type 4</a> (OCA4) is caused by pathogenic variants in <i>SLC45A2</i> (previously called <i>MATP</i> or <i>AIM1</i>). The amount of cutaneous pigmentation in OCA4 ranges from minimal to near normal. Newborns with OCA4 usually have some pigment in their hair, with color ranging from silvery white to light yellow. Hair color may darken with time, but does not vary significantly from childhood to adulthood. This form of albinism is rarer than OCA2, except in the Japanese population.</div></li></ul><p><a href="/books/n/gene/csnb/"><b>Complete congenital stationary night blindness</b></a> is characterized by night blindness (nyctalopia), moderate to severe myopia, normal fundi, complete lack of dark adaptation, and characteristic ERG. A subset of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> nystagmus and mildly reduced visual acuity. The rod (dark-adapted) ERG shows a normal a-wave, indicating normal photoreceptor function, but an undetectable b-wave, indicating post-receptor dysfunction. This response pattern is often referred to as a "negative ERG" because the negative potential of the initial a-wave is not followed by the positive potential of the b-wave. The cone (light-adapted) ERG is mildly reduced and can show a squared-off b-wave caused by loss of the ON-response. The condition is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner and caused by pathogenic variants in <i>NYX</i> (nyctalopin), a member of the leucine-rich proteoglycan family involved in cell adhesion and axon guidance. The protein product is found in ON-bipolar cells connected to both rods and cones.</p><p><a href="/books/n/gene/csnb/"><b>Incomplete congenital stationary night blindness</b></a> is characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> nystagmus, reduced visual acuity, and moderate night-blindness. Iris translucency is not part of the disorder and ERG shows characteristic negative ERG and severely reduced double-peaked cone amplitudes. (The designation "negative ERG" describes an ERG with an a:b wave ratio above unity.) The condition is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner and caused by pathogenic variants in <i>CACNA1F</i> [<a class="bk_pop" href="#x-oa.REF.bechhansen.1998.264">Bech-Hansen et al 1998</a>]. Female carriers are asymptomatic.</p><p><b>Blue cone monochromacy</b> (OMIM <a href="http://omim.org/entry/303700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">303700</a>), sometimes referred to as <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> incomplete achromatopsia, is a rare disorder (&#x0003c;1 in 100,000) characterized by X-linked inheritance, photophobia, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> nystagmus, reduced visual acuity (20/60-20/200), impaired red-green color perception, and characteristic ERG. Fundi are usually normal, but atrophic macular changes have been reported. Formal color vision testing reveals absent or severely reduced responses to red-green stimuli and normal responses to blue stimuli. Standard ERG testing shows absent cone responses with normal rod responses. The S-(blue) cone response is normally undetectable by ERG because S-(blue) cones constitute about 5% of the total cone population. By special techniques, the blue cone response can be amplified and measured in a clinical setting.</p><p>Two common molecular defects are associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#x-oa.REF.nathans.1989.831">Nathans et al 1989</a>]. One is a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of a regulatory sequence (<a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> control region) upstream of the visual pigment genes, which consists of one red pigment (opsin) <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and one or more green (opsin) genes. The second defect involves unequal homologous <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> between red and green opsin genes (coding to a single mutated red opsin) or a 5' red-green hybrid gene having a p.Cys203Arg (c.607T&#x0003e;C, <a href="/nuccore/NM_000513.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000513.2</a>) substitution that encodes for a non-functional protein. A rare third molecular defect found in a single family involved a deletion of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4 in an isolated red gene [<a class="bk_pop" href="#x-oa.REF.ladekjaermikkelsen.1996.403">Ladekjaer-Mikkelsen et al 1996</a>].</p><p><b>Other disorders with sensory retinal early-onset nystagmus</b> include <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> motor nystagmus, <a href="/books/n/gene/achm/">complete and incomplete achromatopsia</a>, blue cone monochromacy, and other <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> stationary cone dysfunctions including enhanced S-cone syndrome, cone dystrophy with supernormal rod response, and <a href="/books/n/gene/lca-ov/">Leber congenital amaurosis</a>. In most of these diagnostic groups, the ERG is essential to establish the diagnosis.</p><p><b><i>PAX6</i> pathogenic variants</b> can result in infantile nystagmus and foveal hypoplasia in individuals with only mild iris hypoplasia (see <a href="/books/n/gene/aniridia/">Aniridia</a>). Such individuals do not have iris transillumination.</p><p>Failure to detect a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GPR143</i> should lead the clinician to re-assess the patient for other non-ocular and constitutional features that will be useful for additional molecular diagnostic studies.</p><p><b>Ocular albinism with sensorineural deafness</b> (OMIM <a href="http://omim.org/entry/103470" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">103470</a>) is characterized by ocular albinism indistinguishable from XLOA (including the presence of macromelanosomes in the skin); additional findings are <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> deafness and vestibular dysfunction. In some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, heterochromia iridis and a prominent white forelock are present. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>. A relation between this disorder and Waardenburg syndrome type 2 has been suggested and may result from <a class="def" href="/books/n/gene/glossary/def-item/digenic/">digenic</a> interaction between a <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a>, <i>MITF</i>, and a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TYR</i> (encoding tyrosinase) [<a class="bk_pop" href="#x-oa.REF.morell.1997.659">Morell et al 1997</a>].</p><p><b>Ocular albinism with late-onset sensorineural deafness</b> (OMIM <a href="http://omim.org/entry/300650" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300650</a>), an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> condition with a disease <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> at Xp22.3, was reported in a large Afrikaner kindred. The disorder is possibly caused by an allelic <i>GPR143</i> variant or a contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> defect [<a class="bk_pop" href="#x-oa.REF.bassi.1999.1604">Bassi et al 1999</a>].</p><p><a href="/books/NBK1287/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><b>Hermansky-Pudlak Syndrome</b></a> (HPS) is a multisystem disorder characterized by: tyrosinase-positive oculocutaneous albinism; a bleeding diathesis resulting from a platelet storage pool deficiency; and, in some cases, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. The albinism is characterized by: hypopigmentation of the skin and hair; and ocular findings of reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. Because of the wide phenotypic variability in the colors of skin and hair in HPS, an observer might initially consider ocular albinism in the differential diagnosis, especially in a person of the less common ethno-geographic backgrounds; however, the clinician should always query the manifestations of the common bleeding diathesis in HPS. HPS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner and is caused by pathogenic variants in <i>HPS1</i>, <i>AP3B1</i> (<i>HPS2</i>), <i>HPS3</i>, <i>HPS4</i>, <i>HPS5</i>, <i>HPS6</i>, <i>DTNBP1</i> (<i>HPS7</i>), <i>BLOC1S3</i> (<i>HPS8</i>), and <i>BLOC1S6</i> (<i>PLDN</i>).</p></div><div id="x-oa.Management"><h2 id="_x-oa_Management_">Management</h2><div id="x-oa.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> ocular albinism (XLOA), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Medical history and physical examination, including a careful evaluation of pigmentation status at birth and later to distinguish between oculocutaneous and ocular albinism</div></li><li class="half_rhythm"><div>A complete ophthalmologic evaluation</div></li><li class="half_rhythm"><div>Dilated retinal examination of any at-risk possible <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> (mother, daughter) for the classic retinal carrier state</div></li><li class="half_rhythm"><div>Dermatologic consultation for sun-protective lotion and sun-protective clothing and avoidance of associated cumulative solar damage</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="x-oa.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Refractive errors should be treated with appropriate spectacle correction as early as possible.</p><p>Photodysphoria can be relieved by sunglasses, transition lenses, or special filter glasses, although many prefer not to wear them because of the reduction in vision from the dark lenses when indoors.</p><p>Abnormal head posture with dampening of the nystagmus in a null point may be modified with prismatic spectacle correction.</p><p>Strabismus surgery is usually not required but may be performed for cosmetic purposes, particularly if the strabismus or the face turn is marked or fixed. The need for vision aids and the educational needs of the visually impaired should be addressed.</p><p>Dermatologic counseling for age-appropriate sun-protective lotions and clothing should be sought.</p></div><div id="x-oa.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Appropriate education for sun-protective lotions and clothing (preferably by an informed dermatologic consultant) is indicated to moderate the cumulative lifelong effects of solar radiation.</p></div><div id="x-oa.Surveillance"><h3>Surveillance</h3><p>Children younger than age 16 years with ocular albinism should have an annual ophthalmologic examination (including assessment of refractive error and the need for filter glasses) and psychosocial and educational support.</p><p>In adults, ophthalmologic examinations should be undertaken when needed, typically every two to three years.</p></div><div id="x-oa.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Although no formal trials exist, standard care avoids use or application of sun-sensitizing drugs or agents.</p></div><div id="x-oa.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#x-oa.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="x-oa.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="x-oa.Other"><h3>Other</h3><p>Nystagmus dampening has been achieved by bilateral horizontal rectus recession surgery in some centers, but this is not a generally accepted treatment nor is there evidence from a comparative clinical trial that such intervention improves the final visual outcome.</p></div></div><div id="x-oa.Genetic_Counseling"><h2 id="_x-oa_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="x-oa.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> ocular albinism is inherited in an X-linked manner.</p></div><div id="x-oa.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have ocular albinism nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>GPR143</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>). Note: If a woman has more than one affected child with the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and no other affected relatives and if the pathogenic variant cannot be detected in her leukocyte DNA, she has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>If <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> analysis reveals that the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, it is appropriate to examine the retina of the mother for evidence of classic mosaic pigmentation of the retinal pigment epithelium. Alternatively, if the <i>GPR143</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the proband is known, the mother should be tested for that pathogenic variant. Possible genetic explanations for a single occurrence of an affected male in the family:</div><ul><li class="half_rhythm"><div class="half_rhythm">The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. In this instance, the proband's mother does not have the pathogenic variant. The only other family members at risk are the offspring of the proband.</div></li><li class="half_rhythm"><div class="half_rhythm">The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s mother has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and may or may not have retinal changes. One of two types of <i>de novo</i> pathogenic variants may be present in the mother:</div><div class="half_rhythm">a. A <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that was present at the time of her conception, is present in every cell of her body, and can be detected in DNA extracted from her leukocytes; or</div><div class="half_rhythm">b. A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that is present only in her ovaries (termed "<a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>") and cannot be detected in DNA extracted from leukocytes. Germline mosaicism has not been reported in XLOA, but it has been observed in many <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorders and should be considered in the <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> of at-risk family members.</div><div class="half_rhythm">Note: In both a and b above, all offspring of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s mother are at risk of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, whereas the sibs of the proband's mother are not.</div></li></ul></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs depends on the genetic status of the mother.</div></li><li class="half_rhythm"><div>If the <i>GPR143</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been detected in the mother&#x02019;s leukocyte DNA, the chance of transmitting the pathogenic variant in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and will usually not be affected.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and the <i>GPR143</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is low but greater than that of the general population because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Germline mosaicism in mothers is not reported in XLOA but has been documented in other <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorders and is likely rare.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not known but the mother of a single <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male has normal fundus pigmentation, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low but is likely to be greater than that of the general population because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> An <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will transmit the <i>GPR143</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to:</p><ul><li class="half_rhythm"><div>All his daughters, who will be heterozygotes and will usually not be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> (see Clinical Description, <a href="#x-oa.Heterozygous_Females">Heterozygous Females</a>);</div></li><li class="half_rhythm"><div>None of his sons.</div></li></ul><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts may be at risk of being carriers and the aunts' offspring, depending on their gender, may be at risk of being carriers or of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p></div><div id="x-oa.Heterozygote_Carrier_Detection"><h3>Heterozygote (Carrier) Detection</h3><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <i>GPR143</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male.</p></div><div id="x-oa.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="x-oa.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>GPR143</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> ocular albinism are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is considered for the purpose of selective termination of pregnancy. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, formal discussion of these issues is appropriate.</p></div></div><div id="x-oa.Resources"><h2 id="_x-oa_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Genetic and Rare Diseases Information Center (GARD)</b></div><div><a href="https://rarediseases.info.nih.gov/gard/8471/ocular-albinism-type-1/resources/1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ocular albinism type 1</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/ocular-albinism" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ocular albinism</a></div></li><li class="half_rhythm"><div><b>National Organization of Albinism and Hypopigmentation (NOAH)</b></div><div>PO Box 959</div><div>East Hampstead NH 03826-0959</div><div><b>Phone:</b> 800-473-2310 (toll-free); 603-887-2310</div><div><b>Fax:</b> 800-648-2310 (toll-free)</div><div><b>Email:</b> info@albinism.org</div><div><a href="http://www.albinism.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.albinism.org</a></div></li><li class="half_rhythm"><div><b>PanAmerican Society for Pigment Cell Research (PASPCR)</b></div><div><a href="http://www.paspcr.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.paspcr.org</a></div></li><li class="half_rhythm"><div><b>The Vision of Children Foundation</b></div><div>11975 El Camino Real</div><div>Suite 104</div><div>San Diego CA 92130</div><div><b>Phone:</b> 858-314-7917</div><div><b>Fax:</b> 858-314-7920</div><div><a href="http://www.visionofchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.visionofchildren.org</a></div></li><li class="half_rhythm"><div><b>eyeGENE - National Ophthalmic Disease Genotyping Network Registry</b></div><div><b>Phone:</b> 301-435-3032</div><div><b>Email:</b> eyeGENEinfo@nei.nih.gov</div><div><a href="https://eyegene.nih.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nei.nih.gov/eyegene</a></div></li></ul></div><div id="x-oa.Molecular_Genetics"><h2 id="_x-oa_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="x-oa.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Ocular Albinism, X-Linked: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1343/table/x-oa.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__x-oa.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_x-oa.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_x-oa.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_x-oa.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_x-oa.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_x-oa.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_x-oa.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_x-oa.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4935" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GPR143</i></a></td><td headers="hd_b_x-oa.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4935" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xp22<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_x-oa.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P51810" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">G-protein coupled receptor 143</a></td><td headers="hd_b_x-oa.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.retina-international.org/files/sci-news/oa1mut.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Retina International Mutations of the OA1 Gene</a><br /><a href="http://www.ifpcs.org/albinism/oa1mut.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Albinism Database Mutations of the Ocular Albinism-1 gene</a></td><td headers="hd_b_x-oa.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GPR143" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GPR143</a></td><td headers="hd_b_x-oa.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GPR143[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GPR143</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="x-oa.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="x-oa.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Ocular Albinism, X-Linked (<a href="/omim/300500,300808" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1343/table/x-oa.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__x-oa.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300500" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300500</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ALBINISM, OCULAR, TYPE I; OA1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300808" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300808</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">G PROTEIN-COUPLED RECEPTOR 143; GPR143</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>GPR143</i> contains nine exons (<a href="/nuccore/NM_000273.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000273.2</a>) spanning 40 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1343/#x-oa.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Normal variants have been reported, including a highly polymorphic dinucleotide repeat (OA1-CA) with more than five different alleles at <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 1 [<a class="bk_pop" href="#x-oa.REF.schiaffino.1995.2319">Schiaffino et al 1995</a>, <a class="bk_pop" href="#x-oa.REF.oetting.2002.85">Oetting 2002</a>].</p><p><b>Pathogenic variants.</b> More than 115 different pathogenic variants have been reported; most appear to be <a class="def" href="/books/n/gene/glossary/def-item/private/">private</a>. They include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, small deletions and insertions, and large deletions covering multiple exons of <i>GPR143</i>. Studies suggest that the spectrum of pathogenic variants (e.g., prevalence of deletions) may vary between the European and North American populations [<a class="bk_pop" href="#x-oa.REF.bassi.1995.13">Bassi et al 1995</a>, <a class="bk_pop" href="#x-oa.REF.rosenberg.1998.570">Rosenberg &#x00026; Schwartz 1998</a>, <a class="bk_pop" href="#x-oa.REF.schnur.1998.800">Schnur et al 1998</a>, <a class="bk_pop" href="#x-oa.REF.bassi.2001.51">Bassi et al 2001</a>, <a class="bk_pop" href="#x-oa.REF.oetting.2002.85">Oetting 2002</a>, <a class="bk_pop" href="#x-oa.REF.camand.2003.167">Camand et al 2003</a>, <a class="bk_pop" href="#x-oa.REF.faug_re.2003.1">Faug&#x000e8;re et al 2003</a>]. (See <a href="/books/NBK1343/#x-oa.molgen.TA">Table A</a>, HGMD and Albinism databases.)</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>GPR143</i> encodes a protein of 404-424 (<a href="/protein/NP_000264.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000264.2</a>) amino acids that is expressed exclusively in the retinal pigment epithelium and the iris pigment epithelium of the eye and in the melanocytes of the skin. The mature <i>GPR143</i> product is a 60-kd pigment cell-specific integral membrane glycoprotein, which represents a novel member of the G-protein coupled receptor (GPCR) superfamily (GPCR-143) [<a class="bk_pop" href="#x-oa.REF.schiaffino.1996.9055">Schiaffino et al 1996</a>]. In contrast to other GPCRs that localize to the plasma membrane, the protein encoded by <i>GPR143</i> is targeted to intracellular organelles and may regulate melanosome biogenesis through signal transduction from the organelle lumen to the cytosol [<a class="bk_pop" href="#x-oa.REF.schiaffino.2005.227">Schiaffino &#x00026; Tacchetti 2005</a>].</p><p>When expressed in COS7 cells that lack melanosomes, GPCR-143 displays a considerable and spontaneous capacity to activate heterotrimeric G proteins and the associated signaling cascade. These findings indicate that heterologously expressed GPCR-143 exhibits two fundamental properties of GPCRs: being capable of activating heterotrimeric G proteins and providing proof that GPCR-143 can actually function as a canonic GPCR in mammalian cells [<a class="bk_pop" href="#x-oa.REF.innamorati.2006.125">Innamorati et al 2006</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most individuals with XLOA have a small intragenic <i>GPR143</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> which results in a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> similar to that observed in those exhibiting a complete <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>GPR143</i>, suggesting that most <i>GPR143</i> alleles are <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a>. Deletions and splice pathogenic variants are expected to produce either no product or rapidly degraded truncated proteins. By expressing mutant proteins in COS cells, pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants could be divided into three groups (I, II, and III) based on the ability to exit the endoplasmic reticulum (ER) and traffic to the lysosomal compartment. Class I pathogenic variants result in a gene product that is unable to exit the ER, presumably because of misfolding. The pathogenesis of these variants is therefore similar to that of the larger deletions/splice pathogenic variants. Class II pathogenic variants exit the ER with low efficiency. Class III pathogenic variants are able to exit the ER and traffic to the lysosomal compartment, and loss of function rather than incorrect trafficking is responsible for the disease in individuals expressing these abnormal alleles [<a class="bk_pop" href="#x-oa.REF.daddio.2000.3011">d'Addio et al 2000</a>, <a class="bk_pop" href="#x-oa.REF.shen.2001.202">Shen et al 2001</a>].</p></div><div id="x-oa.References"><h2 id="_x-oa_References_">References</h2><div id="x-oa.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.bassi.2001.51">Bassi MT, Bergen AA, Bitoun P, Charles SJ, Clementi M, Gosselin R, Hurst J, Lewis RA, Lorenz B, Meitinger T, Messiaen L, Ramesar RS, Ballabio A, Schiaffino MV. Diverse prevalence of large deletions within the OA1 gene in ocular albinism type 1 patients from Europe and North America. <span><span class="ref-journal">Hum Genet. </span>2001;<span class="ref-vol">108</span>:51–4.</span> [<a href="/pubmed/11214907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11214907</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.bassi.1999.1604">Bassi MT, Ramesar RS, Caciotti B, Winship IM, De Grandi A, Riboni M, Townes PL, Beighton P, Ballabio A, Borsani G. X-linked late-onset sensorineural deafness caused by a deletion involving OA1 and a novel gene containing WD-40 repeats. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:1604–16.</span> [<a href="/pmc/articles/PMC1377903/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377903</span></a>] [<a href="/pubmed/10330347" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10330347</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.bassi.1995.13">Bassi MT, Schiaffino MV, Renieri A, De Nigris F, Galli L, Bruttini M, Gebbia M, Bergen AA, Lewis RA, Ballabio A. Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome. <span><span class="ref-journal">Nat Genet. </span>1995;<span class="ref-vol">10</span>:13–9.</span> [<a href="/pubmed/7647783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7647783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.bechhansen.1998.264">Bech-Hansen NT, Naylor MJ, Maybaum TA, Pearce WG, Koop B, Fishman GA, Mets M, Musarella MA, Boycott KM. Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. <span><span class="ref-journal">Nat Genet. </span>1998;<span class="ref-vol">19</span>:264–7.</span> [<a href="/pubmed/9662400" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9662400</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.brodsky.2004.625">Brodsky MC, Fray KJ. Positive angle kappa: a sign of albinism in patients with congenital nystagmus. <span><span class="ref-journal">Am J Ophthalmol. </span>2004;<span class="ref-vol">137</span>:625–9.</span> [<a href="/pubmed/15059699" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15059699</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.camand.2003.167">Camand O, Boutboul S, Arbogast L, Roche O, Sternberg C, Sutherland J, Levin A, Heon E, Menasche M, Dufier J, Abitbol M. Mutational analysis of the OA1 gene in ocular albinism. <span><span class="ref-journal">Ophthalmic Genet. </span>2003;<span class="ref-vol">24</span>:167–73.</span> [<a href="/pubmed/12868035" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12868035</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.charles.1993.222">Charles SJ, Green JS, Grant JW, Yates JR, Moore AT. Clinical features of affected males with X linked ocular albinism. <span><span class="ref-journal">Br J Ophthalmol. </span>1993;<span class="ref-vol">77</span>:222–7.</span> [<a href="/pmc/articles/PMC504486/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC504486</span></a>] [<a href="/pubmed/8494858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8494858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.daddio.2000.3011">d'Addio M, Pizzigoni A, Bassi MT, Baschirotto C, Valetti C, Incerti B, Clementi M, De Luca M, Ballabio A, Schiaffino MV. Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:3011–8.</span> [<a href="/pubmed/11115845" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11115845</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.faug_re.2003.1">Faug&#x000e8;re V, Tuffery-Giraud S, Hamel C, Claustres M. Identification of three novel OA1 gene mutations identified in three families misdiagnosed with congenital nystagmus and carrier status determination by real-time quantitative PCR assay. <span><span class="ref-journal">BMC Genet. </span>2003;<span class="ref-vol">4</span>:1.</span> [<a href="/pmc/articles/PMC140306/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC140306</span></a>] [<a href="/pubmed/12515581" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12515581</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.hegde.2002.7">Hegde M, Lewis RA, Richards CS. Diagnostic DNA testing for X-linked ocular albinism (OA1) with a hierarchical mutation screening protocol. <span><span class="ref-journal">Genet Test. </span>2002;<span class="ref-vol">6</span>:7–14.</span> [<a href="/pubmed/12180081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12180081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.hoffmann.2005.3892">Hoffmann MB, Lorenz B, Morland AB, Schmidtborn LC. Misrouting of the optic nerves in albinism: estimation of the extent with visual evoked potentials. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2005;<span class="ref-vol">46</span>:3892–8.</span> [<a href="/pubmed/16186379" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16186379</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.innamorati.2006.125">Innamorati G, Piccirillo R, Bagnato P, Palmisano I, Schiaffino MV. The melanosomal/lysosomal protein OA1 has properties of a G protein-coupled receptor. <span><span class="ref-journal">Pigment Cell Res. </span>2006;<span class="ref-vol">19</span>:125–35.</span> [<a href="/pmc/articles/PMC1459912/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1459912</span></a>] [<a href="/pubmed/16524428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16524428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.kerrison.1999.600">Kerrison JB, Vagefi MR, Barmada MM, Maumenee IH. Congenital motor nystagmus linked to Xq26-q27. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:600–7.</span> [<a href="/pmc/articles/PMC1377771/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377771</span></a>] [<a href="/pubmed/9973299" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9973299</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.king.1995">King RA, Hearing VJ, Creel DJ, Oetting WS. <em>Albinism</em>. New York, NY: McGraw Hill; 1995.</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.kumar.2011.2306">Kumar A, Gottlob I, McLean RJ, Thomas S, Thomas MG, Proudlock FA. Clinical and oculomotor characteristics of albinism compared to <em>FRMD7</em> associated infantile nystagmus. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2011;<span class="ref-vol">52</span>:2306–13.</span> [<a href="/pubmed/21220551" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21220551</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.ladekjaermikkelsen.1996.403">Ladekjaer-Mikkelsen AS, Rosenberg T, Jorgensen AL. A new mechanism in blue cone monochromatism. <span><span class="ref-journal">Hum Genet. </span>1996;<span class="ref-vol">98</span>:403–8.</span> [<a href="/pubmed/8792812" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8792812</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.lauronen.2005.820">Lauronen L, Jalkanen R, Huttunen J, Carlsson E, Tuupanen S, Lindh S, Forsius H, Sankila EM, Alitalo T. Abnormal crossing of the optic fibres shown by evoked magnetic fields in patients with ocular albinism with a novel mutation in the OA1 gene. <span><span class="ref-journal">Br J Ophthalmol. </span>2005;<span class="ref-vol">89</span>:820–4.</span> [<a href="/pmc/articles/PMC1772728/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1772728</span></a>] [<a href="/pubmed/15965158" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15965158</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.morell.1997.659">Morell R, Spritz RA, Ho L, Pierpont J, Guo W, Friedman TB, Asher JH Jr. Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA). <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:659–64.</span> [<a href="/pubmed/9158138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9158138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.nathans.1989.831">Nathans J, Davenport CM, Maumenee IH, Lewis RA, Hejtmancik JF, Litt M, Lovrien E, Weleber R, Bachynski B, Zwas F, Klingaman R, Fishman G. Molecular genetics of human blue cone monochromacy. <span><span class="ref-journal">Science. </span>1989;<span class="ref-vol">245</span>:831–8.</span> [<a href="/pubmed/2788922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2788922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.oetting.2002.85">Oetting WS. New insights into ocular albinism type 1 (OA1): Mutations and polymorphisms of the OA1 gene. <span><span class="ref-journal">Hum Mutat. </span>2002;<span class="ref-vol">19</span>:85–92.</span> [<a href="/pubmed/11793467" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11793467</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.preising.2011.939">Preising MN, Forster H, Gonser M, Lorenz B. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism. <span><span class="ref-journal">Mol Vis. </span>2011;<span class="ref-vol">17</span>:939–48.</span> [<a href="/pmc/articles/PMC3084229/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3084229</span></a>] [<a href="/pubmed/21541274" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21541274</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.preising.2001.1098">Preising M, Op de Laak JP, Lorenz B. Deletion in the OA1 gene in a family with congenital X linked nystagmus. <span><span class="ref-journal">Br J Ophthalmol. </span>2001;<span class="ref-vol">85</span>:1098–103.</span> [<a href="/pmc/articles/PMC1724103/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1724103</span></a>] [<a href="/pubmed/11520764" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11520764</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.rosenberg.1998.570">Rosenberg T, Schwartz M. X-linked ocular albinism: prevalence and mutations--a national study. <span><span class="ref-journal">Eur J Hum Genet. </span>1998;<span class="ref-vol">6</span>:570–7.</span> [<a href="/pubmed/9887374" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9887374</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.schiaffino.1996.9055">Schiaffino MV, Baschirotto C, Pellegrini G, Montalti S, Tacchetti C, De Luca M, Ballabio A. The ocular albinism type 1 gene product is a membrane glycoprotein localized to melanosomes. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1996;<span class="ref-vol">93</span>:9055–60.</span> [<a href="/pmc/articles/PMC38594/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC38594</span></a>] [<a href="/pubmed/8799153" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8799153</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.schiaffino.1995.2319">Schiaffino MV, Bassi MT, Galli L, Renieri A, Bruttini M, De Nigris F, Bergen AA, Charles SJ, Yates JR, Meindl A, et al.  Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism. <span><span class="ref-journal">Hum Mol Genet. </span>1995;<span class="ref-vol">4</span>:2319–25.</span> [<a href="/pubmed/8634705" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8634705</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.schiaffino.1999.108">Schiaffino MV, d'Addio M, Alloni A, Baschirotto C, Valetti C, Cortese K, Puri C, Bassi MT, Colla C, De Luca M, Tacchetti C, Ballabio A. Ocular albinism: evidence for a defect in an intracellular signal transduction system. <span><span class="ref-journal">Nat Genet. </span>1999;<span class="ref-vol">23</span>:108–12.</span> [<a href="/pubmed/10471510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10471510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.schiaffino.2005.227">Schiaffino MV, Tacchetti C. The ocular albinism type 1 (OA1) protein and the evidence for an intracellular signal transduction system involved in melanosome biogenesis. <span><span class="ref-journal">Pigment Cell Res. </span>2005;<span class="ref-vol">18</span>:227–33.</span> [<a href="/pubmed/16029416" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16029416</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.schmitz.2003.16">Schmitz B, Schaefer T, Krick CM, Reith W, Backens M, Kasmann-Kellner B. Configuration of the optic chiasm in humans with albinism as revealed by magnetic resonance imaging. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2003;<span class="ref-vol">44</span>:16–21.</span> [<a href="/pubmed/12506050" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12506050</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.schnur.1998.800">Schnur RE, Gao M, Wick PA, Keller M, Benke PJ, Edwards MJ, Grix AW, Hockey A, Jung JH, Kidd KK, Kistenmacher M, Levin AV, Lewis RA, Musarella MA, Nowakowski RW, Orlow SJ, Pagon RS, Pillers DA, Punnett HH, Quinn GE, Tezcan K, Wagstaff J, Weleber RG. OA1 mutations and deletions in X-linked ocular albinism. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">62</span>:800–9.</span> [<a href="/pmc/articles/PMC1377018/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377018</span></a>] [<a href="/pubmed/9529334" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9529334</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.schnur.1989.706">Schnur RE, Trask BJ, van den Engh G, Punnett HH, Kistenmacher M, Tomeo MA, Naids RE, Nussbaum RL. An Xp22 microdeletion associated with ocular albinism and ichthyosis: approximation of breakpoints and estimation of deletion size by using cloned DNA probes and flow cytometry. <span><span class="ref-journal">Am J Hum Genet. </span>1989;<span class="ref-vol">45</span>:706–20.</span> [<a href="/pmc/articles/PMC1683435/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1683435</span></a>] [<a href="/pubmed/2573275" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2573275</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.shen.2001.202">Shen B, Rosenberg B, Orlow SJ. Intracellular distribution and late endosomal effects of the ocular albinism type 1 gene product: consequences of disease-causing mutations and implications for melanosome biogenesis. <span><span class="ref-journal">Traffic. </span>2001;<span class="ref-vol">2</span>:202–11.</span> [<a href="/pubmed/11260525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11260525</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.sj_str_m.2001.35">Sj&#x000f6;str&#x000f6;m A, Kraemer M, Ohlsson J, Villarreal G. Subnormal visual acuity syndromes (SVAS): albinism in Swedish 12-13-year-old children. <span><span class="ref-journal">Doc Ophthalmol. </span>2001;<span class="ref-vol">103</span>(3):35–46.</span> [<a href="/pubmed/11824661" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11824661</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.soong.2000.302">Soong F, Levin AV, Westall CA. Comparison of techniques for detecting visually evoked potential asymmetry in albinism. <span><span class="ref-journal">J AAPOS. </span>2000;<span class="ref-vol">4</span>:302–10.</span> [<a href="/pubmed/11040481" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11040481</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.somsen.2014.1268">Somsen D, Davis-Keppen L, Crotwell P, Flanagan J, Munson P, Stein Q. Congenital nasal pyriform aperture stenosis and ocular albinism co-occurring in a sibship with a maternally-inherited 97 kb Xp22.2 microdeletion. <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:1268–71.</span> [<a href="/pubmed/24478262" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24478262</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.trebu_ak_podkraj_ek.2012.167">Trebu&#x00161;ak Podkraj&#x00161;ek K, Stirn Kranjc B, Hovnik T, Kova&#x0010d; J, Battelino T. GPR143 gene mutation analysis in pediatric patients with albinism. <span><span class="ref-journal">Ophthalmic Genet. </span>2012;<span class="ref-vol">33</span>:167–70.</span> [<a href="/pubmed/22486324" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22486324</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.zhang.1993.923">Zhang Y, McMahon R, Charles SJ, Green JS, Moore AT, Barton DE, Yates JR. Genetic mapping of the Kallmann syndrome and X linked ocular albinism gene loci. <span><span class="ref-journal">J Med Genet. </span>1993;<span class="ref-vol">30</span>:923–5.</span> [<a href="/pmc/articles/PMC1016600/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1016600</span></a>] [<a href="/pubmed/8301646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8301646</span></a>]</div></li></ul></div><div id="x-oa.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.king.2001">King RA, Hearing VJ, Creel DJ, Oetting WS. Albinism. In: <em>The Metabolic &#x00026; Molecular Bases of Inherited Disease</em>. 8 ed. New York: McGraw-Hill; 2001:5587-627.</div></li><li class="half_rhythm"><div class="bk_ref" id="x-oa.REF.king.2007">King RA, Oetting WS, Summers CG, Creel DJ, Hearing VJ. Abnormalities in Pigmentation. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, eds. <em>Emery and Rimoin&#x02019;s Principles and Practice of Medical Genetics</em>. 5 ed. New York: Churchill Livingstone Elsevier; 2007:3380-427.</div></li></ul></div></div><div id="x-oa.Chapter_Notes"><h2 id="_x-oa_Chapter_Notes_">Chapter Notes</h2><p><b>Author History</b></p><p>Richard Alan Lewis, MD, MS (2011-present)<br />Thomas Rosenberg, MD; National Eye Clinic for the Visually Impaired, Hellerup (2003-2011)<br />Marianne Schwartz, PhD; Rigshospitalet, Copenhagen (2003-2011)</p><div id="x-oa.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>19 November 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 April 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 May 2006 (me) Comprehensive update posted to live Web site</div></li><li class="half_rhythm"><div>12 March 2004 (me) Review posted to live Web site</div></li><li class="half_rhythm"><div>30 September 2003 (tr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1343</span><span class="label">PMID: <a href="/pubmed/20301517" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301517</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/dfnb9/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/oca1/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1343&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1343/?report=reader">PubReader</a></li><li><a href="/books/NBK1343/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1343" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1343" style="display:none" title="Cite this Page"><div class="bk_tt">Lewis RA. Ocular Albinism, X-Linked. 2004 Mar 12 [Updated 2015 Nov 19]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1343/pdf/Bookshelf_NBK1343.pdf">PDF version of this page</a> (445K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#x-oa.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#x-oa.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#x-oa.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#x-oa.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#x-oa.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#x-oa.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#x-oa.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#x-oa.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#x-oa.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#x-oa.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#x-oa.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4935[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GPR143</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1482358" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1482358" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1482358" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1482358" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301410" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculocutaneous Albinism Type 2</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculocutaneous Albinism Type 2<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lewis RA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301683" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculocutaneous Albinism Type 4</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculocutaneous Albinism Type 4<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hayashi M, Suzuki T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301345" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculocutaneous Albinism Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Oculocutaneous Albinism Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lewis RA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301423" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Congenital Stationary Night Blindness</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Congenital Stationary Night Blindness<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">MacDonald IM, Hoang S, Tuupanen S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24278995" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moog U, Uyanik G, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301517" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301517" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041439dd21425a25d654de">Ocular Albinism, X-Linked - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Ocular Albinism, X-Linked - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:00:25-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89A79AE04134B100000000006C0038&amp;ncbi_session=CE89A79AE0414381_0108SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1343%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1343&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1343/&amp;ncbi_pagename=Ocular Albinism, X-Linked - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89A79AE0414381_0108SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>